LAG3 and cancer: NK cells have emerged as contributors to the effect of cytotoxic T lymphocyte-associated protein 4 (CTLA4), LAG3, and PD-1 in cancer patients, suggesting that immune checkpoint receptors regulate NK cell activity under pathological conditions (226).